Filing Details

Accession Number:
0001140361-13-004305
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-04 10:05:36
Reporting Period:
2013-01-31
Filing Date:
2013-02-04
Accepted Time:
2013-02-04 10:05:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1350577 Ali Naqui One Idexx Drive
Westbrook ME 04092
Corporate Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-01-31 11,498 $41.94 23,418 No 4 M Direct
Common Stock Disposition 2013-01-31 8,540 $95.53 14,878 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-01-31 8,540 $0.00 8,540 $41.94
Common Stock Incentive Stock Option (right to buy) Disposition 2013-01-31 2,958 $0.00 2,958 $41.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-02-13 No 4 M Direct
0 2014-02-13 No 4 M Direct
Footnotes
  1. Grant of options to buy shares of common stock becomes exercisable as to 2,300 shares on 02/14/2008, 02/14/2009 and 02/14/2010 and the remaining 1,640 shares on 02/14/2011.
  2. Grant of options to buy shares of common stock becomes exercisable as to 660 shares on 02/14/2011 and the remaining 2,298 shares on 02/14/2012.